1
|
Zhao Y, Tang P, He X, Xie Y, Cheng W, Xing X, Xing M, Lu X, Liu S, Zhong L. Study on the precise mechanism of Mitoxantrone-induced Jurkat cell apoptosis using surface enhanced Raman scattering. SPECTROCHIMICA ACTA. PART A, MOLECULAR AND BIOMOLECULAR SPECTROSCOPY 2020; 228:117718. [PMID: 31818647 DOI: 10.1016/j.saa.2019.117718] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/02/2019] [Revised: 10/09/2019] [Accepted: 10/26/2019] [Indexed: 06/10/2023]
Abstract
Mitoxantrone (MTX), one representative of anthraquinone ring anticancer drugs, reveals excellent anticancer effects in acute leukemia. Though current studies have shown that MTX-induced acute leukemia cell apoptosis is implemented by inserting into DNA, and then leading to DNA breakage and the subsequent transcription termination, but the specific location information of MTX embedded in DNA remains unknown. In this study, combining surface enhanced Raman scattering (SERS) and principal component analysis (PCA), we achieve the biochemical changes of MTX-induced Jurkat cell apoptosis and the location information of MTX embedded in DNA. In contrast, we also present the corresponding result of Daunorubicin (DNR)-induced Jurkat cell apoptosis. It is found that the location of MTX embedded in DNA of Jurkat cell is different from DNR, in which the action site of MTX is mainly implemented by blocking and destroying AT base pairs while DNR is performed by embedding and destroying GC base pairs and then the base A. Clearly, this achieved information is very useful for the designing and modification of anthraquinone ring anticancer drugs.
Collapse
Affiliation(s)
- Yao Zhao
- Guangdong Provincial Key Laboratory of Nanophotonic Functional Materials and Devices, South China Normal University, Guangzhou 510006, China; Brain Academy of South China Normal University, Guangzhou 510631, China
| | - Ping Tang
- Guangdong Provincial Key Laboratory of Nanophotonic Functional Materials and Devices, South China Normal University, Guangzhou 510006, China
| | - Xuanmeng He
- Guangdong Provincial Key Laboratory of Nanophotonic Functional Materials and Devices, South China Normal University, Guangzhou 510006, China; Brain Academy of South China Normal University, Guangzhou 510631, China
| | - Yue Xie
- Guangdong Provincial Key Laboratory of Nanophotonic Functional Materials and Devices, South China Normal University, Guangzhou 510006, China; Brain Academy of South China Normal University, Guangzhou 510631, China
| | - Wendai Cheng
- Guangdong Provincial Key Laboratory of Nanophotonic Functional Materials and Devices, South China Normal University, Guangzhou 510006, China
| | - Xinyue Xing
- Guangdong Provincial Key Laboratory of Nanophotonic Functional Materials and Devices, South China Normal University, Guangzhou 510006, China
| | - Meishuang Xing
- Guangdong Provincial Key Laboratory of Nanophotonic Functional Materials and Devices, South China Normal University, Guangzhou 510006, China
| | - Xiaoxu Lu
- Guangdong Provincial Key Laboratory of Nanophotonic Functional Materials and Devices, South China Normal University, Guangzhou 510006, China
| | - Shengde Liu
- Guangdong Provincial Key Laboratory of Nanophotonic Functional Materials and Devices, South China Normal University, Guangzhou 510006, China
| | - Liyun Zhong
- Guangdong Provincial Key Laboratory of Nanophotonic Functional Materials and Devices, South China Normal University, Guangzhou 510006, China.
| |
Collapse
|
2
|
Koczurkiewicz P, Klaś K, Grabowska K, Piska K, Rogowska K, Wójcik‐Pszczoła K, Podolak I, Galanty A, Michalik M, Pękala E. Saponins as chemosensitizing substances that improve effectiveness and selectivity of anticancer drug—Minireview of in vitro studies. Phytother Res 2019; 33:2141-2151. [DOI: 10.1002/ptr.6371] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2018] [Revised: 03/25/2019] [Accepted: 03/28/2019] [Indexed: 01/12/2023]
Affiliation(s)
- Paulina Koczurkiewicz
- Department of Pharmaceutical Biochemistry, Faculty of Pharmacy Medical CollegeJagiellonian University Kraków Poland
| | - Katarzyna Klaś
- Department of Pharmaceutical Biochemistry, Faculty of Pharmacy Medical CollegeJagiellonian University Kraków Poland
| | - Karolina Grabowska
- Department of Pharmacognosy, Faculty of Pharmacy Medical CollegeJagiellonian University Kraków Poland
| | - Kamil Piska
- Department of Pharmaceutical Biochemistry, Faculty of Pharmacy Medical CollegeJagiellonian University Kraków Poland
| | - Katarzyna Rogowska
- Department of Pharmaceutical Biochemistry, Faculty of Pharmacy Medical CollegeJagiellonian University Kraków Poland
| | - Katarzyna Wójcik‐Pszczoła
- Department of Pharmaceutical Biochemistry, Faculty of Pharmacy Medical CollegeJagiellonian University Kraków Poland
| | - Irma Podolak
- Department of Pharmacognosy, Faculty of Pharmacy Medical CollegeJagiellonian University Kraków Poland
| | - Agnieszka Galanty
- Department of Pharmacognosy, Faculty of Pharmacy Medical CollegeJagiellonian University Kraków Poland
| | - Marta Michalik
- Department of Cell Biology, Faculty of Biophysics, Biochemistry and BiotechnologyJagiellonian University Kraków Poland
| | - Elżbieta Pękala
- Department of Pharmaceutical Biochemistry, Faculty of Pharmacy Medical CollegeJagiellonian University Kraków Poland
| |
Collapse
|
3
|
Estrogen Enhances the Expression of the Multidrug Transporter Gene ABCG2-Increasing Drug Resistance of Breast Cancer Cells through Estrogen Receptors. Int J Mol Sci 2017; 18:ijms18010163. [PMID: 28098816 PMCID: PMC5297796 DOI: 10.3390/ijms18010163] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2016] [Revised: 01/06/2017] [Accepted: 01/06/2017] [Indexed: 12/16/2022] Open
Abstract
Background: Multidrug resistance is a major obstacle in the successful therapy of breast cancer. Studies have proved that this kind of drug resistance happens in both human cancers and cultured cancer cell lines. Understanding the molecular mechanisms of drug resistance is important for the reasonable design and use of new treatment strategies to effectively confront cancers. Results: In our study, ATP-binding cassette sub-family G member 2 (ABCG2), adenosine triphosphate (ATP) synthase and cytochrome c oxidase subunit VIc (COX6C) were over-expressed more in the MCF-7/MX cell line than in the normal MCF7 cell line. Therefore, we believe that these three genes increase the tolerance of MCF7 to mitoxantrone (MX). The data showed that the high expression of COX6C made MCF-7/MX have more stable on mitochondrial membrane potential (MMP) and reactive oxygen species (ROS) expression than normal MCF7 cells under hypoxic conditions. The accumulation of MX was greater in the ATP-depleted treatment MCF7/MX cells than in normal MCF7/MX cells. Furthermore, E2 increased the tolerance of MCF7 cells to MX through inducing the expression of ABCG2. However, E2 could not increase the expression of ABCG2 after the inhibition of estrogen receptor α (ERα) in MCF7 cells. According to the above data, under the E2 treatment, MDA-MB231, which lacks ER, had a higher sensitivity to MX than MCF7 cells. Conclusions: E2 induced the expression of ABCG2 through ERα and the over-expressed ABCG2 made MCF7 more tolerant to MX. Moreover, the over-expressed ATP synthase and COX6c affected mitochondrial genes and function causing the over-expressed ABCG2 cells pumped out MX in a concentration gradient from the cell matrix. Finally lead to chemoresistance.
Collapse
|
4
|
Li Y, Zhao L, Sun H, Yu J, Li N, Liang J, Wang Y, He M, Bai X, Yu Z, Zheng Z, Mi X, Wang E, Wei M. Gene silencing of FANCF potentiates the sensitivity to mitoxantrone through activation of JNK and p38 signal pathways in breast cancer cells. PLoS One 2012; 7:e44254. [PMID: 22952942 PMCID: PMC3429446 DOI: 10.1371/journal.pone.0044254] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2012] [Accepted: 07/31/2012] [Indexed: 12/21/2022] Open
Abstract
Fanconi anemia complementation group-F (FANCF) is a key factor to maintain the function of FA/BRCA, a DNA-damage response pathway. However, the functional role of FANCF in breast cancer has not been elucidated. In this study, we examined the effects and mechanisms of FANCF-RNAi on the sensitivity of breast cancer cells to mitoxantrone (MX). FANCF silencing by FANCF-shRNA blocked functions of FA/BRCA pathway through inhibition of FANCD2 mono-ubiquitination in breast cancer cell lines MCF-7 and T-47D. In addition, FANCF shRNA inhibited cell proliferation, induced apoptosis, and chromosome fragmentation in both breast cancer cells. We also found that FANCF silencing potentiated the sensitivity to MX in breast cancer cells, accompanying with an increase in intracellular MX accumulation and a decrease in BCRP expression. Furthermore, we found that the blockade of FA/BRCA pathway by FANCF-RNAi activated p38 and JNK MAPK signal pathways in response to MX treatment. BCRP expression was restored by p38 inhibitor SB203580, but not by JNK inhibitor SP600125. FANCF silencing increased JNK and p38 mediated activation of p53 in MX-treated breast cancer cells, activated the mitochondrial apoptosis pathway. Our findings indicate that FANCF shRNA potentiates the sensitivity of breast cancer cells to MX, suggesting that FANCF may be a potential target for therapeutic strategies for the treatment of breast tumors.
Collapse
Affiliation(s)
- Yanlin Li
- Department of Pharmacology, China Medical University, Shenyang City, Liaoning, China
| | - Lin Zhao
- Department of Pharmacology, China Medical University, Shenyang City, Liaoning, China
| | - Haigang Sun
- Department of Pharmacology, China Medical University, Shenyang City, Liaoning, China
| | - Jiankun Yu
- Department of Pharmacology, China Medical University, Shenyang City, Liaoning, China
| | - Na Li
- Department of Pharmacology, China Medical University, Shenyang City, Liaoning, China
| | - Jingwei Liang
- Department of Pharmacology, China Medical University, Shenyang City, Liaoning, China
| | - Yan Wang
- Department of Pharmacology, China Medical University, Shenyang City, Liaoning, China
| | - Miao He
- Department of Pharmacology, China Medical University, Shenyang City, Liaoning, China
| | - Xuefeng Bai
- Department of Pharmacology, China Medical University, Shenyang City, Liaoning, China
| | - Zhaojin Yu
- Department of Pharmacology, China Medical University, Shenyang City, Liaoning, China
| | - Zhihong Zheng
- Institute of Pathophysiology, China Medical University, Shenyang City, Liaoning, China
| | - Xiaoyi Mi
- Institute of Pathophysiology, China Medical University, Shenyang City, Liaoning, China
| | - Enhua Wang
- Institute of Pathophysiology, China Medical University, Shenyang City, Liaoning, China
| | - Minjie Wei
- Department of Pharmacology, China Medical University, Shenyang City, Liaoning, China
- Institute of Pathophysiology, China Medical University, Shenyang City, Liaoning, China
- * E-mail:
| |
Collapse
|
5
|
Feng SX, Guan Q, Chen T, Du C. In vitro activities of 3-hydroxy-1,5,6-trimethoxy-2-methyl-9,10-anthraquinone against non-small cell lung carcinoma. Arch Pharm Res 2012; 35:1251-8. [DOI: 10.1007/s12272-012-0716-4] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2011] [Revised: 02/01/2012] [Accepted: 02/02/2012] [Indexed: 11/24/2022]
|
6
|
Bese N. Radiochemotherapy in the Treatment of Breast Cancer. Clin Oncol (R Coll Radiol) 2009; 21:532-5. [DOI: 10.1016/j.clon.2009.04.005] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2009] [Accepted: 04/23/2009] [Indexed: 01/27/2023]
|
7
|
Bese NS, Munshi A, Budrukkar A, Elzawawy A, Perez CA. Breast radiation therapy guideline implementation in low- and middle-income countries. Cancer 2008; 113:2305-14. [DOI: 10.1002/cncr.23838] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|